The Surface Issue #8, November 2021 edition, was sent to all PSOLVE+ members by email on Tuesday, Nov 23, and can be accessed online here. This edition covers:
Intralesional injections of Candida antigen and bivalent HPV vaccine for common wart treatment
Consensus panel exercise on the practical management of AD with dupilumab Intramatricial secukinumab injections for patients with nail psoriasis
Reflexive BRAF mutational testing for suspected advanced melanoma
Relative risk of skin cancers with different thiazides and thiazide-like diuretics
In this 15-minute video, Dr. Chi-ho Hong and Dr. Mark Kirchhof review the Editor’s Picks, as well as emerging therapies presented at EADV 2021. What did you think were the most impactful sessions at this year’s EADV conference?
This video series was developed by a faculty of Canadian dermatologists from across Canada as part of the C2 Dermatology: Connect & Collaborate learning program. View all C2 Dermatology videos at psolve.org/c2-derm.
In compliance with Innovative Medicines Canada, this program is for Healthcare Professionals only, and is supported by Novartis Pharmaceuticals Canada.
In a real-world setting, is there a correspondence of physician-led disease severity assessments with patient-reported disease severity and impact assessments in patients with moderate-to-severe plaque psoriasis treated with secukinumab? Dr. Mark Kirchhof and Dr. Jon Levy on the 36-month results from the PURE registry as presented at EADV 2021.
This video series was developed by a faculty of Canadian dermatologists from across Canada as part of the C2 Dermatology: Connect & Collaborate learning program. View all C2 Dermatology videos at psolve.org/c2-derm.
In compliance with Innovative Medicines Canada, this program is for Healthcare Professionals only, and is supported by Novartis Pharmaceuticals Canada.
What impact will the novel oral therapy, deucravacitinib, have on the treatment landscape of patients with plaque psoriasis? Dr. Chih-ho Hong and Dr. Gurbir Dhadwal discuss the 52-week efficacy results from the Phase 3 POETYK PSO-1 and POETYK PSO-2 trials as presented at the 30th EADV Congress.
This video series was developed by a faculty of Canadian dermatologists from across Canada as part of the C2 Dermatology: Connect & Collaborate learning program. View all C2 Dermatology videos at psolve.org/c2-derm.
In compliance with Innovative Medicines Canada, this program is for Healthcare Professionals only, and is supported by Novartis Pharmaceuticals Canada.
What is the role of multi-disciplinary care in the management of hidradenitis suppurativa? What are the latest advances in terms of pharmacological and surgical interventions? Dr. Chi-ho Hong and Dr. Jessica Asgarpour present highlights from the Hidradenitis Suppurativa Symposium at the 30th EADV Congress.
This video series was developed by a faculty of Canadian dermatologists from across Canada as part of the C2 Dermatology: Connect & Collaborate learning program. View all C2 Dermatology videos at psolve.org/c2-derm.
In compliance with Innovative Medicines Canada, this program is for Healthcare Professionals only, and is supported by Novartis Pharmaceuticals Canada.
This video series was developed by a faculty of Canadian dermatologists from across Canada as part of the C2 Dermatology: Connect & Collaborate learning program, under the supervision of Dr. Simon Nigen and Dr. Vimal Prajapati. View all AAD C2 Dermatology videos at psolve.org/c2-derm.
In this Video #7, Dr. Jordana Schachter from Montreal, Quebec, presents a 28-minute video update from the 2021 AAD VMX.
* Video is in English. Voir la vidéo en français ci-dessous.
Topics reviewed in this video include:
What’s new in melanoma?
What’s new in atopic dermatitis?
What’s new in acne?
What’s new in alopecia?
What’snewin sunscreens?
What’s new in dysbiosis and inflammation?
What’s new in cosmeceuticals?
What’s new in cosmetic surgery?
In compliance with Innovative Medicines Canada, this program is for Healthcare Professionals only, and is supported by Novartis Pharmaceuticals Canada.
Vous êtes convié(e)s à visionner les Modules vidéos de microapprentissage extraits du programme C2 Dermatology (Connect & Collaborate) Proceedings de l’American Academy of Dermatology Association Virtual Meeting Experience 2021 sous la supervision de Simon Nigen, MD, FRCPC (Montréal, QC) et de Vimal H. Prajapati, MD, FRCPC, FAAD (Calgary, AB). Au cours des prochaines semaines, nous mettrons en ligne les différents Modules selon le calendrier joint: psolve.org/c2-derm
Dans cette vidéo n° 7, la Dre Jordana Schachter (Montréal, QC) présente un résumé de sessions tirées du congrès virtuel de l’AAD 2021.
This video series was developed by a faculty of Canadian dermatologists from across Canada as part of the C2 Dermatology: Connect & Collaborate learning program, under the supervision of Dr. Simon Nigen and Dr. Vimal Prajapati. View all AAD C2 Dermatology videos at psolve.org/c2-derm.
In this Video #6, Dr. Sophia Colantonio from Ottawa, Ontario, presents a 10-minute video update from the 2021 AAD VMX.
Why should the complexity of predicting psoriatic arthritis development in patients with psoriasis lead to an early and aggressive treatment?
How might new data in treating skin and joint manifestations of psoriatic disease influence the patient journey?
How can sustained improvements in nail psoriasis in a broad group of patients with psoriasis or PsA help patient adherence?
In compliance with Innovative Medicines Canada, this program is for Healthcare Professionals only, and is supported by Novartis Pharmaceuticals Canada.
Vous êtes convié(e)s à visionner les Modules vidéos de microapprentissage extraits du programme C2 Dermatology (Connect & Collaborate) Proceedings de l’American Academy of Dermatology Association Virtual Meeting Experience 2021 sous la supervision de Simon Nigen, MD, FRCPC (Montréal, QC) et de Vimal H. Prajapati, MD, FRCPC, FAAD (Calgary, AB). Au cours des prochaines semaines, nous mettrons en ligne les différents Modules selon le calendrier joint: psolve.org/c2-derm
Dans cette vidéo n° 6, la Dre Sophia Colantonio (Ottawa, Ontario) présente un résumé de sessions tirées du congrès virtuel de l’AAD 2021.
Pourquoi la difficulté de prédire si les patients atteints de psoriasis seront également touchés par la polyarthrite psoriasique devrait-elle conduire à un traitement précoce et agressif?
De quelle façon les nouvelles données sur le traitement des manifestations cutanées et articulaires du psoriasis peuvent-elles influencer le parcours du patient?
Comment des améliorations durables du psoriasis des ongles dans un large groupe de patients atteints de psoriasis ou de polyarthrite psoriasique peuvent-elles favoriser le respect du traitement?
En conformité avec Médicaments novateurs Canada, ce programme est réservé aux professionnels de la santé et est parrainé par Novartis Pharma Canada.
This video series was developed by a faculty of Canadian dermatologists from across Canada as part of the C2 Dermatology: Connect & Collaborate learning program, under the supervision of Dr. Simon Nigen and Dr. Vimal Prajapati. View all AAD C2 Dermatology videos at psolve.org/c2-derm.
In this Video #5, Dr. Dominique Fausto de Souza from Montreal, Quebec, presents a 13-minute video update from the 2021 AAD VMX.
* Video is in English. Voir la vidéo en français ci-dessous.
Topics reviewed in this video include:
What impact does emerging clinical data have on the management of plaque psoriasis?
Should we consider re-treatment with a biologic therapy following drug withdrawal and/or relapse?
Are there any new safety signals from trials with biologic therapies?
In compliance with Innovative Medicines Canada, this program is for Healthcare Professionals only, and is supported by Novartis Pharmaceuticals Canada.
Vous êtes convié(e)s à visionner les Modules vidéos de microapprentissage extraits du programme C2 Dermatology (Connect & Collaborate) Proceedings de l’American Academy of Dermatology Association Virtual Meeting Experience 2021 sous la supervision de Simon Nigen, MD, FRCPC (Montréal, QC) et de Vimal H. Prajapati, MD, FRCPC, FAAD (Calgary, AB). Au cours des prochaines semaines, nous mettrons en ligne les différents Modules selon le calendrier joint: psolve.org/c2-derm
Dans cette vidéo n° 5, la Dre Dominique Fausto de Souza (Montréal, QC) présente un résumé de sessions tirées du congrès virtuel de l’AAD 2021.
The Surface Issue #7, October 2021 edition, was sent to all PSOLVE+ members by email on Tuesday, Sep 28, and can be accessed online here. This edition covers:
Concomitant PsA and PsO results from the EXCEED study
Risk of drug exposure in PsO patients on COVID-19 outcomes in France
Treatment of PsO and the natural history of PsA
PASI-HD – a solution for BSA <10%
Survey on the potential impact of a biomarker patch in PsO treatment selection
This video series was developed by a faculty of Canadian dermatologists from across Canada as part of the C2 Dermatology: Connect & Collaborate learning program, under the supervision of Dr. Simon Nigen and Dr. Vimal Prajapati. View all AAD C2 Dermatology videos at psolve.org/c2-derm.
In this Video #4, Dr. Michael Cecchini from Richmond Hill, Ontario, presents a 12-minute video update from the 2021 AAD VMX.
What new options are emerging in the treatment landscape for psoriasis?
How should we manage biologic therapies in patients with psoriasis and obesity?
Are the current treatment approaches for pediatric psoriasis patients sufficient?
Can children with psoriasis be safely treated with biologic therapies?
In compliance with Innovative Medicines Canada, this program is for Healthcare Professionals only, and is supported by Novartis Pharmaceuticals Canada.
Vous êtes convié(e)s à visionner les Modules vidéos de microapprentissage extraits du programme C2 Dermatology (Connect & Collaborate) Proceedings de l’American Academy of Dermatology Association Virtual Meeting Experience 2021 sous la supervision de Simon Nigen, MD, FRCPC (Montréal, QC) et de Vimal H. Prajapati, MD, FRCPC, FAAD (Calgary, AB). Au cours des prochaines semaines, nous mettrons en ligne les différents Modules selon le calendrier joint: psolve.org/c2-derm
Dans cette vidéo n° 4, le Dr Michael Cecchini (Richmond Hill, Ontario) présente un résumé de sessions tirées du congrès virtuel de l’AAD 2021.
